Skip to main content
. 2019 Mar 25;12:2159–2170. doi: 10.2147/OTT.S194745

Figure 3.

Figure 3

Kaplan–Meier (log-rank test) survival estimate: standard vs modified FIrB/FOx regimens.

Notes: Progression-free survival: 14.4 months vs 14.4 months; P=0.8589. Overall survival: 37.8 months vs 26.6 months; P=0.7746.